Ambra Quote - 0LR3 | ADVFN

S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
UK
LSE
Ambra Sa (0LR3) Share Price

Ambra Sa (0LR3)

14.25

0.00

( 0.00% )

Updated: 11:00:00

Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Current Price

14.25

Bid

0.00

Offer

0.00

Volume

0.00

0.00 Day's Range 0.00

14.25 52 Week Range 14.25

Market Cap

Previous Close

14.25

Open

-

Last Trade

Last Trade Time

-

Financial Volume

-

VWAP

-

Average Volume (3m)

0.00

Shares Outstanding

25,207,000

Dividend Yield

-

PE Ratio

6.52

Earnings Per Share (EPS)

2.18

Revenue

919.24M

Net Profit

55.06M

Sector

Wine & Alcoholic Bev-whsl

Industry

Wine & Alcoholic Bev-whsl

Website

www.ambra.com.pl

Headquarters

Warsaw, Pol

Founded

-

Ambra Sa is listed in the Wine & Alcoholic Bev-whsl sector of the London Stock Exchange with ticker 0LR3. The last closing price for Ambra was PLN14.25. Over the last year, Ambra shares have traded in a share price range of PLN 14.25 to PLN 14.25.

Ambra currently has 25,207,000 shares in issue. The market capitalisation of Ambra is PLN359.20 million. Ambra has a price to earnings ratio (PE ratio) of 6.52.

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	14.25	14.25	14.25	0	0	DE
4	0	0	14.25	14.25	14.25	0	0	DE
12	0	0	14.25	14.25	14.25	0	0	DE
26	0	0	14.25	14.25	14.25	0	0	DE
52	0	0	14.25	14.25	14.25	0	0	DE
156	0	0	14.25	14.25	14.25	0	0	DE
260	0	0	14.25	14.25	14.25	0	0	DE

0LR3 - Frequently Asked Questions (FAQ)

What is the current Ambra share price?

The current share price of Ambra is PLN 14.25

How many Ambra shares are in issue?

Ambra has 25,207,000 shares in issue

What is the market cap of Ambra?

The market capitalisation of Ambra is PLN 359.2M

What is the 1 year trading range for Ambra share price?

Ambra has traded in the range of PLN 14.25 to PLN 14.25 during the past year

What is the PE ratio of Ambra?

The price to earnings ratio of Ambra is 6.52

What is the cash to sales ratio of Ambra?

The cash to sales ratio of Ambra is 0.39

What is the reporting currency for Ambra?

Ambra reports financial results in PLN

What is the latest annual turnover for Ambra?

The latest annual turnover of Ambra is PLN 919.24M

What is the latest annual profit for Ambra?

The latest annual profit of Ambra is PLN 55.06M

What is the registered address of Ambra?

The registered address for Ambra is UL. PULAWSKA 336, WARSAW, 02-819

What is the Ambra website address?

The website address for Ambra is www.ambra.com.pl

Which industry sector does Ambra operate in?

Ambra operates in the WINE & ALCOHOLIC BEV-WHSL sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WSGWestminster Group Plc	1.40p (27.27%)	2.57M
WHRWarehouse Reit Plc	98.80p (16.51%)	5.43M
MET1Metals One Plc	0.575p (15.00%)	1.8M
ZENZenith Energy Ltd.	7.75p (14.81%)	1.97M
CORCorpus Resources Plc	0.016p (14.29%)	186.59M
SAVESavannah Energy Plc	9.30p (-64.57%)	160.62M
VELAVela Technologies Plc	0.003p (-40.00%)	852.85M
TIGTeam Internet Group Plc	59.20p (-39.96%)	3.25M
ALBAAlba Mineral Resources	0.014p (-24.32%)	80.81M
SYMESupply@me Capital Plc	0.003p (-23.08%)	19.14M
VELAVela Technologies Plc	0.003p (-40.00%)	852.85M
TRPTower Resources Plc	0.023p (-2.13%)	201.66M
CORCorpus Resources Plc	0.016p (14.29%)	186.59M
SAVESavannah Energy Plc	9.30p (-64.57%)	160.62M
TOMTomco Energy Plc	0.0425p (-19.05%)	149.88M

gedi8

gedi8 2 minutes ago

We will see my friend. His first month in office has really hurt the market. I hope you are right

WooptdooU

WooptdooU 3 minutes ago

Why don't these GRIFTERS use their OWN money and buy at the market.... they are NOT AFRAID of the helplessly hopeful pennylongs.

louieforpar

louieforpar 3 minutes ago

Less than four one way or another.

glenn1919

glenn1919 4 minutes ago

INLF....................................................................................p/m

uranium-pinto-beans

uranium-pinto-beans 5 minutes ago

OKTA
Okta upgraded to Buy from Neutral at DA Davidson
DA Davidson analyst Rudy Kessinger upgraded Okta to Buy from Neutral with a price target of $125, up from $90. The company reported "very strong" Q4 results and meaningfully raised its fiscal 2026 guidance, the analyst tells inve

WooptdooU

WooptdooU 5 minutes ago

These scummy insiders have done NOTHING but TAKE...they must believe the helplessly hopeful pennylongs are harmless to them.

uranium-pinto-beans

uranium-pinto-beans 6 minutes ago

mmmm

https://www.bloomberg.com/news/articles/2025-03-03/citi-copy-paste-error-almost-sent-6-billion-to-wealth-account

uranium-pinto-beans

uranium-pinto-beans 7 minutes ago

OKTA
Okta price target raised to $100 from $94 at Canaccord
Canaccord raised the firm's price target on Okta to $100 from $94 and keeps a Hold rating on the shares. The firm said they reported resoundingly positive Q4 results ahead of both the firm's and consensus expectations with

uranium-pinto-beans

uranium-pinto-beans 8 minutes ago

MCHP
Microchip cyclical bottom may be forming, says JPMorgan

Jefedejefes

Jefedejefes 9 minutes ago

listening to your favorite song... over, and over, and over https://www.youtube.com/watch?v=BfnjX88Va4Y

docj

docj 13 minutes ago

"One example: the current CEO of Cytodyn was CMO under Nader Pourhassan the Frauder, and was fine with all his actions."

That is a false statement. It is a matter of public record how Dr JL felt about Nader. Stop trying to make it look like he was complicit with Nader's actions. It lo

meixatech

meixatech 14 minutes ago

"Oral bioavailability" is one of the most important properties in drug design and development. A high oral bioavailability reduces the amount of an administered drug necessary to achieve a desired pharmacological effect and therefore could reduce the risk of side-effects and toxicity.

trader53

trader53 14 minutes ago

Nixon's Restaurants have not gone belly up

https://investorshub.advfn.com/uicon/155361.png?cb=636360310707230000
______________________________________________________________________

Nixon Restaurant Group Inc
is operated in Colorado ,

gp22

gp22 15 minutes ago

$ESLA @ $1.05....Given $16 one year target last week by highly regarded bio/pharma ETF...Hit $1.80s 2 weeks ago and backed off..$ESLA a repeat of Immuno $IOVA & $SMMT monster moves
Link: 9/29/24
https://finance.yahoo.com/news/estrella-immunopharma-achieves-complete-response-160000432.h

WooptdooU

WooptdooU 16 minutes ago

Grifter siraj...eom

StockWorkOrange

StockWorkOrange 19 minutes ago

Aw. Someone is upset their Picture Pump didn't work this time. Oh well. I'm sure you'll come up with something new to get these bAABBoons to hand over some more money.......

hedge_fun

hedge_fun 20 minutes ago

They’ll need to be careful with their…….,

updates, won’t they?

They say the device pinpoints treasure, right?

If they’re diving and coming up empty, then Houston, don’t we have a problem?

Of course they could always be doing something wit

StockWorkOrange

StockWorkOrange 20 minutes ago

We all see how well you and the pump crew are doing on X with your 20 likes. Keep up the good work Alidare. It really seems to be working......#ticktock

glenn1919

glenn1919 20 minutes ago

AEON.......SPPL........RETO........PTIX.........................................................................p/m

WeTheMarket

WeTheMarket 21 minutes ago

UK, any comments on the Earnings Report/10K? Are you still out and plan to stay out or do you see signs of hope for the future?

glenn1919

glenn1919 22 minutes ago

AEON..........................................https://stockcharts.com/h-sc/ui?s=AEON&p=W&b=5&g=0&id=p86431144783

Jackxkr

Jackxkr 23 minutes ago

At this moment what happens after approval is not as worrying as getting approval. As each day passes chances of approval goes down from here.

edbi46

edbi46 25 minutes ago

On REDDIT 3 months ago:
RecoveryRx now available through prosthetics for pain management, ortho, PT
Veterans Health Administration
VA providers now have access to recently FDA-approved non-opioid, non-invasive pain management device through RecoveryRx. RecoveryRx produces an el

BNP PARIBAS ISSUANCE

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions